Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Immunol Res. 2011 Oct;51(1):39-44. doi: 10.1007/s12026-011-8238-6.
The three members of the amyloid precursor protein family in mammals [amyloid precursor protein, amyloid precursor-like protein 1, and amyloid precursor-like protein 2 (APLP2)] have been implicated in a large array of intracellular processes, which include development, transcription, apoptosis, metabolism, and the cell cycle. A series of studies by our laboratories has demonstrated that APLP2 is highly expressed by many cancer cell lines (with the highest expression in pancreatic cancer cell lines) and that it facilitates major histocompatibility complex (MHC) class I molecule endocytosis. This review focuses on this recently revealed function of APLP2 relevant to tumor immunology: that it acts as a novel regulator of MHC class I molecule surface expression.
哺乳动物淀粉样前体蛋白家族的三个成员[淀粉样前体蛋白、淀粉样前体样蛋白 1 和淀粉样前体样蛋白 2(APLP2)]已被涉及到一系列的细胞内过程,包括发育、转录、细胞凋亡、代谢和细胞周期。我们实验室的一系列研究表明,APLP2 在许多癌细胞系中高度表达(在胰腺癌细胞系中表达最高),并促进主要组织相容性复合物(MHC)I 类分子内吞作用。这篇综述重点介绍了 APLP2 最近在肿瘤免疫学方面的新功能:它是 MHC I 类分子表面表达的新型调节剂。